Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enova International, Inc.ENVA · Entity 3836 | Chief Strategy Officer | August 05, 2026 | August 07, 2026 |
| Lifeway Foods, Inc.LWAY · Entity 891 | Director | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enova International, Inc.
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy) with limited SARSEC Table II · derivative / convertible security · Conversion / exercise price $257.79 · Expires 2033-08-05 | Direct | 2,095 |
Reported balance
After 2026-08-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 2,095 · Balance 2,095 F1: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
F2: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
F3: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.
Lifeway Foods, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 2,195 |
Reported balance
After 2026-09-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-30 · Grant · Acquired 782 · Balance 2,195 F3: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F4: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,512 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance 2,512 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest on December 30, 2026 contingent on the Reporting Person's continued service as a Director on such vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,038 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 2,038 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest on December 30, 2026 contingent on the Reporting Person's continued service as a Director on such vesting date. F2: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest on December 30, 2026 contingent on the Reporting Person's continued service as a Director on such vesting date.
F2: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on such vesting date.
F3: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
F4: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 00:53 UTC | Lifeway Foods, Inc. LWAY · Entity 891 | GrantPhantom Stock · Derivative | 782 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-26-007540 · ownership.xml · derivative · entry 3 Chartier Kirk · CIK 0001483333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,195 Underlying: Common Stock · 782 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F4 · derivative.exercise_price: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. F3 · price: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F4 · price: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. F3 · derivative.exercise_date: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F4 · derivative.exercise_date: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. F3 · derivative.expiration_date: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F4 · derivative.expiration_date: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended September 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,095 | $0.00 Strike: $257.79 | $0.00 |
DisclosureSEC source: 0001483333-26-000002 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,095 Underlying: Common stock; par value $0.00001 per share · 2,095 shares Expires 2033-08-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:00 UTC | Lifeway Foods, Inc. LWAY · Entity 891 | GrantRestricted Stock Units · Derivative | 2,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-26-005257 · ownership.xml · derivative · entry 2 Chartier Kirk · CIK 0001483333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,038 Underlying: Common Stock · 2,038 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3 · price: The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on such vesting date. F3 · derivative.exercise_date: The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on such vesting date. F3 · derivative.expiration_date: The RSUs vest on July 1, 2027 contingent on the Reporting Person's continued service as a Director on such vesting date. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 21:00 UTC | Lifeway Foods, Inc. LWAY · Entity 891 | GrantPhantom Stock · Derivative | 556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-26-005257 · ownership.xml · derivative · entry 3 Chartier Kirk · CIK 0001483333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,413 Underlying: Common Stock · 556 shares Expires not disclosed F4 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F5 · price: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended June 30, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. F4 · derivative.exercise_date: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F4 · derivative.expiration_date: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 3,038 | $0.00 Strike: $166.88 | $0.00 |
DisclosureSEC source: 0001193125-26-226928 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,038 Underlying: Common stock; par value $0.00001 per share · 3,038 shares Expires 2033-05-13 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:00 UTC | Lifeway Foods, Inc. LWAY · Entity 891 | GrantPhantom Stock · Derivative | 857 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-26-002622 · ownership.xml · derivative · entry 2 Chartier Kirk · CIK 0001483333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 857 Underlying: Common Stock · 857 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F4 · price: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended March 31, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. F3 · derivative.exercise_date: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. F3 · derivative.expiration_date: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,938 | $0.00 Strike: $157.79 | $0.00 |
DisclosureSEC source: 0001193125-26-051512 · ownership.xml · derivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,938 Underlying: Common stock; par value $0.00001 per share · 2,938 shares Expires 2033-02-11 F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantCommon stock, par value $0.00001 per share | 4,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-051512 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,972 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030. Read SEC document |
| February 08, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 1,791 | $161.10 | $288,530.10 |
DisclosureSEC source: 0001193125-26-043120 · ownership.xml · nonDerivative · entry 4 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,399 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 08, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 3,099 | $161.10 | $499,248.90 |
DisclosureSEC source: 0001193125-26-043120 · ownership.xml · nonDerivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,190 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 1,421 | $161.10 | $228,923.10 |
DisclosureSEC source: 0001193125-26-043120 · ownership.xml · nonDerivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,289 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 795 | $159.78 | $127,025.10 |
DisclosureSEC source: 0001193125-26-043120 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,710 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 21:15 UTC | Lifeway Foods, Inc. LWAY · Entity 891 | GrantRestricted Stock Units · Derivative | 2,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-25-009450 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,512 Underlying: Common Stock · 2,512 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: The RSUs vest on December 30, 2026 contingent on the Reporting Person's continued service as a Director on such vesting date. F2 · derivative.expiration_date: The RSUs vest on December 30, 2026 contingent on the Reporting Person's continued service as a Director on such vesting date. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 3,878 | $0.00 Strike: $128.00 | $0.00 |
DisclosureSEC source: 0001193125-25-274374 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,878 Underlying: Common stock; par value $0.00001 per share · 3,878 shares Expires 2032-11-06 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 6, 2026, November 6, 2027 and November 6, 2028. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 17,000 | $0.00 Strike: $20.73 | $0.00 |
DisclosureSEC source: 0000950170-25-108963 · ownership.xml · derivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,283 Underlying: Common stock; par value $0.00001 per share · 17,000 shares Expires 2027-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022 and February 11, 2023. F5 · balance_after: Reflects the number of shares underlying unexercised options solely with respect to the Reporting Person's February 11, 2020 stock option award. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | SaleCommon stock, par value $0.00001 per share | 17,000 | $108.80 | $1,849,550.70 |
DisclosureSEC source: 0000950170-25-108963 · ownership.xml · nonDerivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,505 F1 · price: This transaction was executed in multiple trades at prices ranging from $108.30 to $109.285. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionCommon stock, par value $0.00001 per share | 17,000 | $20.73 | $352,410.00 |
DisclosureSEC source: 0000950170-25-108963 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 4,178 | $0.00 Strike: $103.92 | $0.00 |
DisclosureSEC source: 0000950170-25-105104 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,178 Underlying: Common stock; par value $0.00001 per share · 4,178 shares Expires 2032-08-06 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 6, 2026, August 6, 2027 and August 6, 2028. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 4,616 | $0.00 Strike: $99.22 | $0.00 |
DisclosureSEC source: 0000950170-25-073602 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,616 Underlying: Common stock, par value $0.00001 per share · 4,616 shares Expires 2032-05-14 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 14, 2026, May 14, 2027 and May 14, 2028. Read SEC document |
| February 09, 2025 Filed Feb 10, 2025 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 5,520 | $114.86 | $634,027.20 |
DisclosureSEC source: 0000950170-25-017257 · ownership.xml · nonDerivative · entry 4 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,505 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 08, 2025 Filed Feb 10, 2025 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 1,791 | $114.86 | $205,714.26 |
DisclosureSEC source: 0000950170-25-017257 · ownership.xml · nonDerivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,025 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 08, 2025 Filed Feb 10, 2025 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 3,099 | $114.86 | $355,951.14 |
DisclosureSEC source: 0000950170-25-017257 · ownership.xml · nonDerivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,816 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 1,473 | $116.49 | $171,589.77 |
DisclosureSEC source: 0000950170-25-017257 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,915 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connection with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 4,108 | $0.00 Strike: $112.94 | $0.00 |
DisclosureSEC source: 0000950170-25-016484 · ownership.xml · derivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,108 Underlying: Common stock, par value $0.00001 per share · 4,108 shares Expires 2032-02-05 F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 5, 2026, February 5, 2027 and February 5, 2028. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 23:00 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantCommon stock, par value $0.00001 per share | 6,807 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-016484 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,388 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 5, 2026, February 5, 2027, February 5, 2028 and February 5, 2029. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 4,400 | $0.00 Strike: $89.33 | $0.00 |
DisclosureSEC source: 0000950170-24-123420 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,400 Underlying: Common stock; par value $0.00001 per share · 4,400 shares Expires 2031-11-05 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 5, 2025, November 5, 2026, and November 5, 2027. Read SEC document |
| October 28, 2024 Filed Oct 30, 2024 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 17,644 | $0.00 Strike: $23.96 | $0.00 |
DisclosureSEC source: 0000950170-24-119040 · ownership.xml · derivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock; par value $0.00001 per share · 17,644 shares Expires 2026-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021 and February 12, 2022. F5 · balance_after: Reflects the number of shares underlying unexercised options solely with respect to the Reporting Person's February 12, 2019 stock option award. Read SEC document |
| October 28, 2024 Filed Oct 30, 2024 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | SaleCommon stock, par value $0.00001 per share | 17,644 | $86.80 | $1,531,462.15 |
DisclosureSEC source: 0000950170-24-119040 · ownership.xml · nonDerivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,422 F1 · price: This transaction was executed in multiple trades at prices ranging from $86.355 to $87.71. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| October 28, 2024 Filed Oct 30, 2024 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionCommon stock, par value $0.00001 per share | 17,644 | $23.96 | $422,750.24 |
DisclosureSEC source: 0000950170-24-119040 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,066 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2024 Filed Nov 7, 2024 21:30 UTC Amendment | Enova International, Inc. ENVA · Entity 3836 | SaleCommon stock, par value $0.00001 per share | 4,841 | $87.71 | $424,604.11 |
DisclosureSEC source: 0000950170-24-123417 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,581 F1 · kind: The original Form 4, filed October 30, 2024, is being amended by this Form 4 Amendment solely to correct an administrative error, which omitted a sale of 4,481 shares at a sale price of $87.71. As a result of the administrative error, the total number of securities beneficially owned following the transaction should be reported as 112,581. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:30 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 4,965 | $0.00 Strike: $76.47 | $0.00 |
DisclosureSEC source: 0000950170-24-094797 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,965 Underlying: Common stock; par value $0.00001 per share · 4,965 shares Expires 2031-08-07 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 7, 2025, August 7, 2026, and August 7, 2027. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 30,819 | $0.00 Strike: $20.85 | $0.00 |
DisclosureSEC source: 0000950170-24-064095 · ownership.xml · derivative · entry 4 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock; par value $0.00001 per share · 30,819 shares Expires 2025-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 13, 2019, February 13, 2020 and February 13, 2021. F6 · balance_after: Reflects the number of shares underlying unexercised options solely with respect to the Reporting Person's February 13, 2018 stock option award. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:00 UTC | Enova International, Inc. ENVA · Entity 3836 | SaleCommon stock, par value $0.00001 per share | 10,484 | $60.15 | $630,630.42 |
DisclosureSEC source: 0000950170-24-064095 · ownership.xml · nonDerivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,422 F2 · price: This transaction was executed in multiple trades at prices ranging from $59.85 to $60.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:00 UTC | Enova International, Inc. ENVA · Entity 3836 | SaleCommon stock, par value $0.00001 per share | 30,819 | $60.16 | $1,853,981.66 |
DisclosureSEC source: 0000950170-24-064095 · ownership.xml · nonDerivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,906 F1 · price: This transaction was executed in multiple trades at prices ranging from $59.84 to $61.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:00 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionCommon stock, par value $0.00001 per share | 30,819 | $20.85 | $642,576.15 |
DisclosureSEC source: 0000950170-24-064095 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2024 Filed May 10, 2024 22:00 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 5,342 | $0.00 Strike: $62.60 | $0.00 |
DisclosureSEC source: 0000950170-24-057995 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,342 Underlying: Common stock; par value $0.00001 per share · 5,342 shares Expires 2031-05-08 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 8, 2025, May 8, 2026, and May 8, 2027. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:31 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 15,000 | $20.85 Strike: $61.73 | $312,750.00 |
DisclosureSEC source: 0000950170-24-023371 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,649 Underlying: Common stock, par value $0.00001 per share · 15,000 shares Expires 2025-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.429 to $62.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 13, 2019, February 13, 2020 and February 13, 2021. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 21:24 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 2,820 | $55.54 | $156,622.80 |
DisclosureSEC source: 0000950170-24-013868 · ownership.xml · nonDerivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,906 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:24 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 5,520 | $55.54 | $306,580.80 |
DisclosureSEC source: 0000950170-24-013868 · ownership.xml · nonDerivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,726 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:24 UTC | Enova International, Inc. ENVA · Entity 3836 | Tax withholdingCommon stock, par value $0.00001 per share | 4,995 | $54.57 | $272,577.15 |
DisclosureSEC source: 0000950170-24-013868 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,246 F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:25 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 6,211 | $0.00 Strike: $54.04 | $0.00 |
DisclosureSEC source: 0000950170-24-012800 · ownership.xml · derivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,649 Underlying: Common stock, par value $0.00001 per share · 6,211 shares Expires 2031-02-06 F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 6, 2025, February 6, 2026 and February 6, 2027. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:25 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantCommon stock, par value $0.00001 per share | 12,822 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012800 · ownership.xml · nonDerivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,241 F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 6, 2025, February 6, 2026, February 6, 2027 and February 6, 2028. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 00:38 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 20,217 | $14.80 Strike: $50.02 | $299,211.60 |
DisclosureSEC source: 0000950170-23-070526 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,438 Underlying: Common stock, par value $0.00001 · 20,217 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.83 to $50.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 17, 2018, February 17, 2019 and February 17, 2020. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 19:32 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 14,000 | $14.80 Strike: $44.19 | $207,200.00 |
DisclosureSEC source: 0000950170-23-069000 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,655 Underlying: Common stock, par value $0.00001 · 14,000 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.859 to $44.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 17, 2018, February 17, 2019 and February 17, 2020. Read SEC document |
| November 02, 2023 Filed Nov 7, 2023 01:20 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 6,646 | $0.00 Strike: $41.49 | $0.00 |
DisclosureSEC source: 0000950170-23-059659 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,655 Underlying: Common stock, par value $0.00001 per share · 6,646 shares Expires 2030-11-02 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 2, 2024, November 2, 2025 and November 2, 2026. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 20:14 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 5,000 | $14.80 Strike: $49.73 | $74,000.00 |
DisclosureSEC source: 0000950170-23-049182 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,009 Underlying: Common stock, par value $0.00001 · 5,000 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.59 to $49.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 17, 2018, February 17, 2019 and February 17, 2020. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 20:55 UTC | Enova International, Inc. ENVA · Entity 3836 | GrantNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 6,085 | $0.00 Strike: $55.22 | $0.00 |
DisclosureSEC source: 0000950170-23-038112 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,009 Underlying: Common stock, par value $0.00001 per share · 6,085 shares Expires 2030-08-02 F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 2, 2024, August 2, 2025 and August 2, 2026. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 19:07 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,000 | $14.80 Strike: $52.52 | $29,600.00 |
DisclosureSEC source: 0000950170-23-028556 · ownership.xml · derivative · entry 1 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,924 Underlying: Common stock, par value $0.00001 · 2,000 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 17, 2018, February 17, 2019 and February 17, 2020. Read SEC document |
| June 13, 2023 Filed Jun 13, 2023 21:51 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 3,000 | $14.80 Strike: $51.44 | $44,400.00 |
DisclosureSEC source: 0000950170-23-027787 · ownership.xml · derivative · entry 3 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,924 Underlying: Common stock, par value $0.00001 · 3,000 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 17, 2018, February 17, 2019 and February 17, 2020. Read SEC document |
| June 12, 2023 Filed Jun 13, 2023 21:51 UTC | Enova International, Inc. ENVA · Entity 3836 | Exercise / conversionNon-Qualified Stock Option (right to buy) with limited SAR · Derivative | 2,000 | $14.80 Strike: $51.29 | $29,600.00 |
DisclosureSEC source: 0000950170-23-027787 · ownership.xml · derivative · entry 2 Chartier Kirk · CIK 0001483333 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,924 Underlying: Common stock, par value $0.00001 · 2,000 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. F3 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates: February 17, 2018, February 17, 2019 and February 17, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.